Our findings uncover the MISP‐MST1/2‐SLC7A11 axis as a key mediator in lung cancer progression and provide support for the connection between MISP and ferroptosis, offering significant therapeutic implications for YAP‐driven tumors. This evidence concerns the gene MST1 and lung carcinoma.